Cargando…
PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ireland Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629141/ http://dx.doi.org/10.1016/S0167-8140(21)07625-8 |
| _version_ | 1784607144660697088 |
|---|---|
| author | Wong, H. Lim, F. Cheng, A. |
| author_facet | Wong, H. Lim, F. Cheng, A. |
| author_sort | Wong, H. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8629141 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ireland Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-86291412021-11-30 PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic Wong, H. Lim, F. Cheng, A. Radiother Oncol Digital Poster: Lung Elsevier Ireland Ltd. 2021-08 2021-09-28 /pmc/articles/PMC8629141/ http://dx.doi.org/10.1016/S0167-8140(21)07625-8 Text en Copyright © 2021 Elsevier Ireland Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Digital Poster: Lung Wong, H. Lim, F. Cheng, A. PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic |
| title | PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic |
| title_full | PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic |
| title_fullStr | PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic |
| title_full_unstemmed | PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic |
| title_short | PO-1174 3-weekly paclitaxel-carboplatin with radiation for stage III NSCLC – option during COVID-19 pandemic |
| title_sort | po-1174 3-weekly paclitaxel-carboplatin with radiation for stage iii nsclc – option during covid-19 pandemic |
| topic | Digital Poster: Lung |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629141/ http://dx.doi.org/10.1016/S0167-8140(21)07625-8 |
| work_keys_str_mv | AT wongh po11743weeklypaclitaxelcarboplatinwithradiationforstageiiinsclcoptionduringcovid19pandemic AT limf po11743weeklypaclitaxelcarboplatinwithradiationforstageiiinsclcoptionduringcovid19pandemic AT chenga po11743weeklypaclitaxelcarboplatinwithradiationforstageiiinsclcoptionduringcovid19pandemic |